Dali Medical Devices
Dali Medical Devices is an Israeli private medical-device company that designs and licenses disposable safety needles, auto-injectors, and a connected IoT syringe to pharmaceutical and biotech partners for self-administered drug delivery and patient-compliance applications.
- Company typePrivate
- Founded2003
- HeadquartersRishon Le Zion, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Dali Medical Devices does
Dali Medical Devices Ltd. ("DALI") is a privately held Israeli medical-device company founded in 2003 and headquartered in Yavne. It designs, develops, and licenses disposable injectable drug-delivery devices — principally safety needles, auto-injectors, and a connected IoT syringe — for pharmaceutical, biosimilar, and biotech partners that need differentiated, patient-friendly delivery systems for self-administered chronic-disease therapies.
Its core technology falls into three product lines. The SAN family (SAN-L, SAN-Light, SAN-P, SAN-DV, SAN-DV Pro) provides automatic needle insertion, hidden-needle design, and passive sharps protection while letting patients control injection speed manually. The Flexi-Q auto-injector family (PFS, DV, mMU, EAI, HV) is developed in collaboration with E3D/Elcam Medical, which owns and commercializes the platform; Flexi-Q DV is FDA 510(k) cleared and Flexi-Q PFS has a US Device Master File. The SYNNECT connected digital syringe adds IoT/BLE connectivity, administration alerts, and cloud data transmission for remote patient monitoring. DALI holds multiple granted patents across the US, EU, and Israel protecting these mechanisms, and operates an ISO 13485-certified quality system.
DALI monetizes through B2B device licensing, customization, and contract development services for pharma and medical-device companies. Pricing is quote-based and not publicly disclosed. Distribution for auto-injectors is via partner E3D/Elcam Medical, while safety needles and SYNNECT are sold direct under licensing arrangements. The company targets pharma customers seeking lifecycle management and adherence benefits, with one disclosed commercial launch to date (SAN-Light customized for ADVANZ PHARMA's lanreotide product, CE marked October 2023). Co-founders David Daily (CEO) and Lior Raday (CTO) also spun out Everads Therapy in 2017 to pursue ophthalmic suprachoroidal injection technology.
Dali Medical Devices firmographics
Firmographics- Name
- Dali Medical Devices
- Legal name
- DALI Medical Devices Ltd.
- Website
- https://dalimed.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dali Medical Devices is an Israeli private medical-device company that designs and licenses disposable safety needles, auto-injectors, and a connected IoT syringe to pharmaceutical and biotech partners for self-administered drug delivery and patient-compliance applications.
- Ownership category
- akta.pro rank
Dali Medical Devices industry classification
Industry- Product category
- Drug Delivery Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Auto-Injectors (Disposable & Reusable) (HLAHAIAB)
- akta.pro secondary industries
- Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM), Prefilled Syringes & Safety Syringes (HLAHAIAA), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Dali Medical Devices is headquartered
LocationHeadquarters
- HQ city
- Rishon Le Zion
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Dali Medical Devices business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Revenue model
- Device Manufacturing and Licensing: DALI manufactures and licenses injectable drug delivery devices to pharmaceutical companies. Devices are offered as market-ready products or customized per specific pharmaceutical partner requirements. Auto-injectors are assigned/licensed to Elcam Medical while DALI maintains development and co-development partnerships.
- Custom Development Services: DALI provides contract development services from concept to commercialization, including design, verification and validation testing, regulatory support through relevant standards and regulations.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Dali Medical Devices product offering
Product offeringCore offering
DALI Medical Devices develops, manufactures, and licenses injectable drug delivery devices for pharmaceutical partners, including the SAN family of automatic safety needles, the SYNNECT connected IoT digital syringe, and the Flexi-Q family of disposable auto-injectors. The company provides end-to-end services from concept and design through verification, validation, regulatory support, and commercialization, offering both market-ready products and customized devices tailored to specific drug delivery requirements.
Product overview
DALI Medical Devices offers a comprehensive portfolio of injectable drug delivery devices organized into three main product lines: SAN (Safe Auto Needle) family for automatic safety needles and syringes, SYNNECT for connected digital syringes with IoT capabilities, and Flexi-Q family for auto-injectors. The SAN products include SAN-L for luer syringes, SAN-Light passive safety needle, SAN-P for prefilled syringes, and SAN-DV/DV Pro for drugs in vials. The SYNNECT connected syringe adds digital health features including injection monitoring and cloud connectivity. The Flexi-Q auto-injector family covers prefilled syringes (PFS), drugs in vials (DV), multi-dose use (mMU), emergency auto-injectors (EAI), and high-viscosity drugs (HV). The company partners with E3D (Elcam Drug Delivery Devices) for auto-injector development and commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- SAN (Safe Auto Needle) Product Family: A variety of injecting devices designed for Sharps Injury Prevention (SIP) and Safety Engineered Devices (SED), enabling safe and easy self-injection experience.
- Flexi-Q Auto-Injector Family
- SYNNECT
Products and services
- SAN-L Single-use sterile automatic safety needle for any type of luer syringe, combining automatic needle insertion, passive sharps protection, and hidden needle while allowing manual control of injection speed. Designed for pharmaceutical partners and self-injecting patients.
- SAN-Light Single-use sterile passive safety needle for any type of luer syringe, combining automatic needle shielding and hidden needle design for healthcare professionals and self-injecting patients.
- SAN-P Disposable self-injection solution for staked-needle prefilled syringes combining automatic needle insertion, passive sharps protection, and hidden needle with manual injection speed control.
- SAN-DV Fully disposable automatic needle with vial adaptor for use with drugs in vials, reducing patient anxiety and allowing control of injection speed.
- SAN-DV Pro Fully disposable automatic needle with integrated vial adaptor for easy drug reconstitution and mixing, designed for use with drugs in vials with automatic needle insertion and hidden needle.
- SYNNECT Connected IoT syringe that adds sensing and connectivity technologies to regular syringes, monitoring injection process, providing administration alerts, and transmitting data via BLE to cloud for remote patient monitoring in clinical trials and marketed drugs.
- Flexi-Q PFS Fully disposable auto-injector for prefilled syringes with passive needle shielding, designed to encourage patient compliance in self-injection.
- Flexi-Q DV FDA 510(k) cleared fully disposable auto-injector for drugs in vials (lyophilized and liquid forms), providing unique user-friendly self-administration solution with simplified reconstitution and safe needle shielding.
- Flexi-Q mMU Auto-injector with reusable driving unit and disposable cassette for prefilled syringes and vials, designed for chronic diseases requiring frequent injections with reduced cost per injection.
- Flexi-Q EAI 2-step fully disposable auto-injector for 1 mL or 2.25 mL pre-filled syringes with passive needle shielding for subcutaneous and intramuscular injection.
- Flexi-Q HV Fully disposable auto-injector for low to high viscosity liquid drugs in prefilled syringes with proprietary damping mechanism, flexible delivery volumes of 0.1–1.0 mL.
Quantifiable outcome
- Reduced local skin reactions through injection that starts only after full needle penetration
- +2 more outcomes
Companies that use Dali Medical Devices
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Dali Medical Devices technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Dali Medical Devices partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, supporting and major.
- Everads TherapycoreIn 2017, DALI co-founded Everads Therapy together with co-founders David and Lior, the Rad-Biomed incubator, and Sheba Tel Hashomer (City of Health). Everads Therapy is an Israeli startup developing a novel system for effective suprachoroidal injection based on invention by Dr. Ygal Rotenstreich. Everads represents DALI's spin-off company.
- Rad-Biomed IncubatorsupportingCo-investor in Everads Therapy spin-off company established in 2017 along with DALI co-founders and Sheba Tel Hashomer.
- Sheba Tel Hashomer (City of Health)supportingMedical center partner in co-founding Everads Therapy. Dr. Ygal Rotenstreich's invention for suprachoroidal injection forms the basis of Everads' novel injection system.
- E3D (Elcam Drug Delivery Devices)coreDALI has a licensing and contract development agreement with E3D, Elcam Drug Delivery Devices (sister company of Elcam Medical), covering a variety of auto-injectors for self-administration. DALI invents and develops the injectors in collaboration with Elcam. The FDA 510(k) clearance of the Flexi-Q DV auto-injector resulted from this long, stable, and mutually beneficial partnership spanning over 15 years.
- ADVANZ PHARMAmajorA customized version of DALI's SAN-Light passive safety needle was CE marked and launched by ADVANZ PHARMA for lanreotide (MYTOLAC/MYRELEZ) drug product. This represents a successful product launch with a pharmaceutical partner.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Dali Medical Devices competitors and assessment
Company assessmentDirect peers
- Ypsomed Holding AG: Swiss manufacturer of disposable auto-injectors (YpsoMate) and pen injectors serving global pharma and biotech customers. Directly competes with DALI's Flexi-Q family in the disposable auto-injector category with similar customization and licensing models.
- SHL Medical: Leading developer and manufacturer of advanced drug delivery systems including Molly, Maggie, and DAI auto-injectors. Directly competes with DALI's Flexi-Q family across disposable auto-injector formats serving biologic and biosimilar pharma partners.
- Elcam Medical: Israeli medical device company and DALI's long-standing strategic partner through its E3D subsidiary. Both companies are direct peers in disposable auto-injector development, with Elcam owning/commercializing the Flexi-Q family that DALI invented.
- Owen Mumford: UK-based manufacturer of auto-injectors (Aidaptus), safety syringes, and pre-filled syringe platforms for global pharma. Directly comparable to DALI's SAN safety needle and Flexi-Q auto-injector families targeting self-injection and life-cycle management use cases.
Broad incumbents
- Gerresheimer AG: German specialty glass and plastics manufacturer producing syringes, auto-injectors, and drug delivery devices. Provides comparable prefilled syringe and auto-injector solutions to pharma customers, overlapping with DALI's Flexi-Q and SAN portfolios.
- Stevanato Group: Italian drug containment and delivery solutions provider offering syringes, vials, and auto-injector platforms. Now encompasses the Haselmeier auto-injector business, directly competing with DALI's Flexi-Q family across disposable and reusable auto-injector formats.
- West Pharmaceutical Services: Global leader in primary packaging and drug delivery devices including auto-injectors, prefilled syringes, and connected platforms (e.g., SmartDose). Directly comparable to DALI in serving pharma customers with injectable device platforms, but at significantly larger scale.
- BD (Becton, Dickinson and Company): Global medical technology company with a substantial Pharmaceutical Systems segment offering prefilled syringes, auto-injectors, and safety systems. Broad incumbent competing with DALI across multiple product categories with greater scale and global reach.
Emerging players
- Enable Injections: US-based developer of large-volume wearable injectors (enFuse) for subcutaneous delivery of high-volume biologics. Operates in an adjacent but expanding category that could compete with or complement DALI's Flexi-Q HV high-viscosity disposable platform.
- Credence MedSystems: US-based developer of innovative injectable drug delivery systems including the Credence Connect auto-injector with companion app for adherence monitoring. Directly comparable to DALI's SYNNECT connected syringe strategy, with overlapping focus on connected/compliance-enhancing delivery.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Dali Medical Devices social profiles
Digital presenceDali Medical Devices compliance and trust
Trust signalCompliance1 record
Dali Medical Devices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dali Medical Devices leadership team
Management profileNumber of profiles
Profiles6 records
Dali Medical Devices subsidiaries and ownership
Company hierarchySubsidiaries1 record
Dali Medical Devices funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dali Medical Devices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dali Medical Devices
What does Dali Medical Devices do?
DALI Medical Devices develops, manufactures, and licenses injectable drug delivery devices for pharmaceutical partners, including the SAN family of automatic safety needles, the SYNNECT connected IoT digital syringe, and the Flexi-Q family of disposable auto-injectors. The company provides end-to-end services from concept and design through verification, validation, regulatory support, and commercialization, offering both market-ready products and customized devices tailored to specific drug delivery requirements.
Is Dali Medical Devices a public or private company?
Dali Medical Devices is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dali Medical Devices founded?
Dali Medical Devices was founded in 2003. It employs 11 to 50 people.
Where is Dali Medical Devices based?
Dali Medical Devices is headquartered in Rishon Le Zion, Israel, in the Middle East region.
How does Dali Medical Devices make money?
Two revenue lines are on record. Device Manufacturing and Licensing is the primary driver. The others are custom Development Services.
Who are Dali Medical Devices's main competitors?
Direct peers on record are Ypsomed Holding AG, SHL Medical, Elcam Medical and Owen Mumford. Broad incumbents are Gerresheimer AG, Stevanato Group, West Pharmaceutical Services and BD (Becton, Dickinson and Company). Emerging players are Enable Injections and Credence MedSystems.
Does Dali Medical Devices have an API?
No public API is recorded for Dali Medical Devices.
What industry is Dali Medical Devices in?
Dali Medical Devices's product category is Drug Delivery Devices. Its primary akta.pro industry code is HLAHAIAB, Auto-Injectors (Disposable & Reusable), with a secondary code of HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps). Its NAICS code is 339112 and its SIC code is 3841.